Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury. (41/50)

 (+info)

Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. (42/50)

 (+info)

A3 adenosine receptor inhibition improves the efficacy of hypertonic saline resuscitation. (43/50)

 (+info)

Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors. (44/50)

 (+info)

Xanthines as adenosine receptor antagonists. (45/50)

 (+info)

Disparity in FcepsilonRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine. (46/50)

 (+info)

Investigational A(3) adenosine receptor targeting agents. (47/50)

 (+info)

Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor. (48/50)

 (+info)